Jan-Lukas Førde
- Postdoc; PhD
- +47 22781814
Publications 2024
Impact of the Graphene Production Methods Sonication and Microfluidization on In Vitro and In Vivo Toxicity, Macrophage Response, and Complement Activation
ACS Omega, 9 (39), 40468-40476
DOI 10.1021/acsomega.4c03189, PubMed 39372034
The Rac1-inhibitor EHop-016 attenuates AML cell migration and enhances the efficacy of daunorubicin in MOLM-13 transplanted zebrafish larvae
Transl Oncol, 40, 101876
DOI 10.1016/j.tranon.2024.101876, PubMed 38185059
Publications 2023
Development of nanoparticles based on amphiphilic cyclodextrins for the delivery of active substances
Int J Pharm, 651, 123723
DOI 10.1016/j.ijpharm.2023.123723, PubMed 38110013
Ocrelizumab and ofatumumab, but not rituximab, trigger complement induction in vitro
Int Immunopharmacol, 124 (Pt B), 111021
DOI 10.1016/j.intimp.2023.111021, PubMed 37816262
Publications 2022
Graphene-based phenformin carriers for cancer cell treatment: a comparative study between oxidized and pegylated pristine graphene in human cells and zebrafish
Nanoscale Adv, 4 (6), 1668-1680
DOI 10.1039/d1na00778e, PubMed 36134366
A new software tool for computer assisted in vivo high-content analysis of transplanted fluorescent cells in intact zebrafish larvae
Biol Open, 11 (12)
DOI 10.1242/bio.059530, PubMed 36355409
Publications 2021
Improved pH-Responsive Release of Phenformin from Low-Defect Graphene Compared to Graphene Oxide
ACS Omega, 6 (38), 24619-24629
DOI 10.1021/acsomega.1c03283, PubMed 34604644
Repurposing chlorpromazine for anti-leukaemic therapy by nanoparticle encapsulation
Int J Pharm, 612, 121296
DOI 10.1016/j.ijpharm.2021.121296, PubMed 34793932